Reprint

Molecular Biology of Colorectal Cancers

Edited by
March 2024
206 pages
  • ISBN978-3-7258-0427-6 (Hardback)
  • ISBN978-3-7258-0428-3 (PDF)

This is a Reprint of the Special Issue Molecular Biology of Colorectal Cancers that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

Colorectal cancer (CRC) was one of the first tumors in which the molecular mechanisms of carcinogenesis were investigated and confirmed. We now recognize that tumors appearing identical under microscopic examination exhibit molecular differences, and this explains the diverse patient outcomes commonly encountered in clinical practice. Despite their similar appearance, cancers are inherently distinct. However, even in the era of molecular medicine and targeted therapies, the majority of patients with metastatic CRC ultimately succumb to the disease, experiencing a diminished quality of life and a significant number of years of potential life lost. This is especially true as younger individuals increasingly fall victim to this illness. Much remains to be understood regarding the mechanisms contributing to the carcinogenesis and temporal evolution of CRC. This Special Issue is dedicated to recent research exploring the molecular mechanisms underlying CRC, encompassing multi-omics analyses and environmental interactions with diagnostic, prognostic, or predictive value. A fascinating world is open to research, and we hope to shed further light on the biology of this common yet still lethal tumor. We are delighted to embark on this journey with our colleagues, as today's scientific progress relies on collaboration between clinicians and basic scientists. We hope you enjoy this Special Issue.

Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
colorectal cancer; microRNAs; microarray gene-expression profiling; molecular classification; prognostic factors; colorectal cancer; flow cytometry; immunophenotype; diagnostic model; differentially expressed genes; colorectal cancer; microbiome; 16S rRNA sequencing; screening; diagnosis; colorectal cancer; signaling pathways; chemoresistance; epithelial-to-mesenchymal transition; organoids; UBQLN1; ERK-c-Myc pathway; colorectal cancer; cancer progression; colorectal cancer; microRNA; prognosis; biomarker; rectal cancer; colorectal cancer; cancer stem cells; OCT4; oncofetal protein; colorectal cancer; preclinical models; bioluminescence imaging; cell lines; spheroids; xenograft tumors; CMS classification; colorectal cancer; cell proliferation; genetic and epigenetic markers; cell cycle-related antigens; prognostic markers; cyclins; PCNA; Ki-67 antigen; ncRNAs; immunohistochemistry; qRT-PCR; RNA/DNA sequencing; ABCC4; ABCG2; CRC; immune cell infiltration; metastasis; CRC subpopulations; CRC diagnostic and prognostic biomarkers